Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review Sakine ShirvalilouSamideh KhoeiParvin Mirzaghavami Topic Review 13 March 2021 Pages: 419 - 428
Neuropsychological outcomes following supratotal resection for high‐grade glioma: a review Joanna K. TaborDavid BondaRandy S. D’Amico Topic Review 21 March 2021 Pages: 429 - 437
Long-term disease control and treatment outcomes of stereotactic radiosurgery in cavernous sinus meningiomas Rafael Martinez-PerezWilliam Florez-PerdomoA. Samy Youssef Topic Review 27 March 2021 Pages: 439 - 449
Racial and ethnic disparities among children with primary central nervous system tumors in the US Edwin Nieblas-BedollaBriana ChristophersAnaliz Rodriguez Topic Review 28 March 2021 Pages: 451 - 466
Adjuvant therapeutic potential of moderate hypothermia for glioblastoma Clémentine FulbertStéphan ChabardèsDavid Ratel Laboratory Investigation 19 March 2021 Pages: 467 - 482
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage? Sina BurthMona OhmannSimon Nagel Clinical Study Open access 05 March 2021 Pages: 483 - 490
Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patients Anne-Sophie MonteroSuzanne TranBertrand Mathon Clinical Study 23 February 2021 Pages: 491 - 499
Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial Maximilien VermandelClément DupontNicolas Reyns Clinical Study 20 March 2021 Pages: 501 - 514
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma Mary Jane Lim-FatKun Wei SongIsabel Arrillaga-Romany Clinical Study 01 March 2021 Pages: 515 - 522
Fluid attenuation in non‐contrast‐enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma Sohil H. PatelPrem P. BatchalaRajan Jain Clinical Study 04 March 2021 Pages: 523 - 531
LAG-3 expression in the inflammatory microenvironment of glioma Maximilian J. MairBarbara KieselAnna S. Berghoff Clinical Study Open access 02 March 2021 Pages: 533 - 539
Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies Maher KurdiNadeem Shafique ButtShadi Alkhayyat Clinical Study Open access 04 March 2021 Pages: 541 - 549
Predicting response to radiotherapy of intracranial metastases with hyperpolarized \(^{13}\)C MRI Casey Y. LeeHany SolimanCharles H. Cunningham Clinical Study Open access 19 March 2021 Pages: 551 - 557
Useful hearing preservation is improved in vestibular schwannoma patients who undergo stereotactic radiosurgery before further hearing deterioration ensues Akiyoshi OginoHao LongHideyuki Kano Clinical Study 17 March 2021 Pages: 559 - 566
An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity Harrison NaungKenneth J. Cohen Clinical Study 10 March 2021 Pages: 567 - 572
Preferential tumor localization in relation to 18F-FDOPA uptake for lower‐grade gliomas Hiroyuki TatekawaHiroyuki UetaniBenjamin M. Ellingson Clinical Study 11 March 2021 Pages: 573 - 582
Distinct imaging patterns of pseudoprogression in glioma patients following proton versus photon radiation therapy Reed RitterbuschLia M. HalaszJerome J. Graber Clinical Study 22 March 2021 Pages: 583 - 590
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases Matthew N. MillsChetna ThawaniKamran A. Ahmed Clinical Study 19 March 2021 Pages: 591 - 601
Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US Quinn T. OstromHalle L. KrebsJill S. Barnholtz-Sloan Clinical Study 23 March 2021 Pages: 603 - 615
Spontaneous pneumocephalus associated with a melanoma brain metastasis: a Case Report JungEun AhnAdomas BuneviciusJason Sheehan Letter to the Editor 09 March 2021 Pages: 617 - 619
Correction to: Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc Sankaradoss ArunShantha RavisankarArambakkam Janardhanam Vanisree Correction 24 March 2021 Pages: 621 - 622